• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Treat sexually transmitted infections with antibiotics, antivirals

Article

Sexually Transmitted infections (STIs) such as syphilis, gonorrhea, herpes and chlamydia are a major health concern in the United States.

Ideally, treatment for STIs would include testing sexual partners of infected persons, and treating them if they're infected as well. However, this can be difficult to accomplish. "Empiric or expedited partner treatment is gaining popularity," says Gianna Zuccotti, MD, MPH, deputy editor of The Medical Letter on Drugs and Therapeutics, a nonprofit newsletter that critically appraises drugs. "This approach means that the physician gives medication to the infected person to give to their partner, rather than requiring the partner to come in. Expedited partner treatment is increasingly used by physicians who care for people with STIs. It means you can't do partner counseling or HIV testing, but it has the advantage of increasing treatment access for people who might not come in on their own."

GONORRHEA AND SYPHILIS The number of gonorrhea cases in the U.S. currently is at an all-time low. The number varies dramatically among the states, ranging from 265 per 100,000 in Louisiana, to 5 per 100,000 in Idaho. Single doses of oral antibiotics are highly effective for gonorrhea, but untreated cases can lead to epididymitis in men, pelvic inflammatory disease and ectopic pregnancy in women, and infertility in both men and women.

GENITAL HERPES Genital herpes is a very common viral infection, causing recurrent clusters of blisters or bumps in the genital area. Many people carry the infection without any symptoms, and can unknowingly transmit the virus to a sexual partner. Between the late 1970s and the early 1990s, the number of Americans with genital herpes increased 30%. Currently about 45 million people have genital herpes; that's one out of every five adolescents and adults. Although the infection can stay in the body indefinitely, the number of outbreaks tends to decrease over time.

The severity and duration of herpes symptoms and the frequency of attacks can be reduced by antiviral agents such as Zovirax (acyclovir), Famvir (famciclovir), and Valtrex (valacyclovir). These medicines are taken orally for 7 to 10 days to shorten the initial herpes outbreak, and can be used in lower doses to prevent or suppress recurrences. "Some people keep the medicine on hand and start treatment when they feel the first signs of an outbreak," Dr. Zuccotti says.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.